The U.S. Department of Health and Human Services Office of the Inspector General (OIG) released a report last week summarizing the findings of its audit of the National Institutes of Health’s (NIH) grant awards to EcoHealth Alliance, NIH’s monitoring of EcoHealth, and EcoHealth’s use of grant funds, including its monitoring of subawards to a foreign entity. The audit examined three NIH awards to EcoHealth totaling approximately $8 million, which included $1.8 million of EcoHealth’s subawards to eight subrecipients, including the Wuhan Institute of Virology (WIV). OIG concludes that despite identifying potential risks associated with research being performed under the EcoHealth awards, NIH did not effectively monitor or take timely action to address EcoHealth’s compliance with some requirements. Other deficiencies in the oversight of the awards identified by OIG include NIH’s improper termination of a grant; EcoHealth’s inability to obtain scientific documentation from WIV; and EcoHealth’s improper use of grant funds, resulting in $89,171 in unallowable costs. The report will be discussed during a congressional hearing scheduled for February 1 before the House Energy and Commerce Subcommittee on Oversight and Investigations.
Membership of the Select Subcommittee on the Coronavirus Pandemic
House Speaker Kevin McCarthy (R-Calif.) named the members of the Select Subcommittee on the Coronavirus Pandemic last week. The panel, which was established by the new rules package adopted by the House of Representatives earlier this month, will be comprised of Chair Brad Wenstrup (R-Ohio) alongside Reps. Nicole Malliotakis (R-N.Y.), Mariannette Miller-Meeks (R-Iowa), Debbie Lesko (R-Ariz.), Michael Cloud (R-Texas), John Joyce (R-Pa.), Marjorie Taylor Greene (R-Ga.), Ronny Jackson (R-Texas) and Rich McCormick (R-Ga.). The subcommittee, which is housed within the House Committee on Oversight and Accountability, has been charged with investigating the origins of COVID-19, the use of taxpayer funding and relief programs to address the pandemic, the efficacy of the federal government’s pandemic preparedness and response to the spread of COVID-19, and the nation’s implementation of vaccine policies.
Health Panel Leadership Preview Agendas for 118th Congress
House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-Wash.) announced last week that Rep. Brett Guthrie (R-Ky.) will serve as the new chair of panel’s Health Subcommittee. Guthrie has previewed his agenda for the 118th Congress, stating that he plans to focus on health care price transparency, issues related to fentanyl, drug scheduling, and mental health, and expanding access to telehealth in a sustainable way.
Rep. Vern Buchanan (R-Fla.) will serve as chair of the Ways and Means Health Subcommittee, as well as the vice chair of the full panel. Buchanan was a co-chair of the Republicans’ Healthy Future Task Force last congress, which focused on the opioid crisis, modernizing health care delivery, and reducing health care costs. Rep. Lloyd Doggett (D-Texas) will continue to serve as the subcommittee’s ranking member. Doggett has said that his top priority will be protecting Medicare from any Republican attempts to scale back the program, while ensuring equitable access to telehealth and preventing telehealth fraud and abuse represents a potential area of bipartisan compromise.
On the Senate side, Finance Committee Chair Ron Wyden (D-Ore.) has discussed his plans to expand upon his previous work on the CHRONIC Care Act. The law, spearheaded by Wyden and the late Sen. Orrin Hatch (R-Utah), expanded access to telehealth in the Medicare Advantage program as well as at-home dialysis care. In addition to further allowing Medicare to pay for nonmedical services for people with chronic conditions, Wyden also plans to focus on the role of pharmacy benefit managers and mental health issues – including payment parity, workforce challenges, and ghost networks – in the 118th Congress. Wyden has also pledged to investigate broader health care workforce issues such as nursing shortages.
Hart Health Strategies Inc. continues to track the latest committee leadership and roster announcements in our Guide to the 118th Congress, which is updated on an ongoing basis. This living document provides a list of health professionals serving in Congress, House and Senate leadership, congressional health committee members, and biographies on new members of Congress.
Schiff Announces Run for CA Senate Seat
Rep. Adam Schiff (D-Calif.) announced that he will run for Sen. Dianne Feinstein’s (D-Calif.) seat in the Senate in 2024. Schiff served as the lead prosecutor during the first impeachment trial of former President Donald Trump in 2020. Feinstein has yet to announce whether she will run for re-election, but the five-term senator, 89, is widely expected to retire.
GAO Releases New Report on Pandemic Relief Funds
The Government Accountability Office (GAO) released a report last week reviewing how the U.S. Department of Health and Human Services (HHS) allocated certain pandemic relief funds to support communities disproportionately affected by COVID-19. The report provides details about the $75 billion provided by HHS to four agencies – the Centers for Disease Control and Prevention, the Health Resources and Services Administration, the Indian Health Service, and the Office of Minority Health – which directed about $29 billion (over 35%) to support these communities. The agencies distributed another $33 billion – often to state health departments – with a recommendation to support these communities. GAO found that state officials often faced delays in acceptance of federal funds as well as capacity challenges that constrained their efforts to allocate and use the funds.
FDA Panel Recommends Harmonizing COVID-19 Vaccines
The Food and Drug Administration’s (FDA’s) Vaccines and Related Biological Products Advisory Committee (VRBPAC) unanimously voted to recommend matching the composition of primary COVID-19 vaccine doses and booster doses during its meeting last week. This would result in the phasing out of the original COVID-19 vaccine and making all COVID-19 vaccines consist of the updated bivalent dose. If the VRBPAC’s recommendation is endorsed by the FDA and the CDC, a single vaccine composed of the updated bivalent shot will be used for both vaccinated and unvaccinated people going forward.
Advocates Celebrate Elimination of X-Waiver at White House Event
The Biden administration recognized the end of the x-waiver requirement in an event featuring federal officials, substance use disorder treatment advocates, and legislative champions at the White House last week. The Mainstreaming Addiction Treatment (MAT) Act, which was included in the year-end omnibus legislation signed into law late last year, eliminates the special training and required waiver process for prescribers of the opioid use disorder treatment buprenorphine. Supporters of the change say that elimination of the burdensome x-waiver requirement will increase access to addiction treatment, reduce the number of fatal opioid overdoses, and lessen the stigma around the use and prescription of buprenorphine.
POLICY BRIEFINGS
CDC Announces Internal Reorganization
The Centers for Disease Control and Prevention (CDC) announced several internal structural changes to the agency last week. Most of the CDC will now report directly to the Immediate Office of the Director, a change from the structure known as “Community of Practice” previously in place. According to staff familiar with the changes, a centralized leadership team of multi-disciplinary experts including the CDC director, chief of staff, and several deputy directors will be created to supervise the agency. The Center for Surveillance, Epidemiology, and Laboratory Services and the Center for State, Tribal, Local, and Territorial Support will be combined into a new agency entity called the National Center for State, Tribal, Local, and Territorial Public Health Infrastructure and Workforce. The Center for Preparedness and Response will be renamed the Office of Readiness and Response. Several new offices will also be created, including the Office of Health Equity and the Office of Public Health Data, Surveillance, and Technology. The reorganization follows Director Rochelle Walensky’s recognition last year that the CDC’s performance in responding to the COVID-19 pandemic did not meet expectations.
Upcoming Congressional Hearings and Markups
House Rules Committee meeting on H.J. Res. 7 – Relating to a national emergency declared by the President on March 13, 2020; H.R. 139 – SHOW UP Act; H.R. 382 – Pandemic is Over Act; and H.R. 497 – Freedom for Health Care Workers Act; 5:00 p.m.; January 30
House Energy and Commerce Subcommittee on Health hearing “Lives Worth Living: Addressing the Fentanyl Crisis, Protecting Critical Lifelines, and Combatting Discrimination Against Those with Disabilities;” 10:00 a.m.; February 1
House Oversight and Accountability Committee hearing “Federal Pandemic Spending: A Prescription for Waste, Fraud and Abuse;” 10:00 a.m.; February 1
House Energy and Commerce Subcommittee on Oversight and Investigations hearing “Challenges and Opportunities to Investigating the Origins of Pandemics and Other Biological Events;” 2:00 p.m.; February 1
Recently Introduced Health Legislation
H.R.445 – To establish within the Department of Health and Human Services an Ombuds for Reproductive and Sexual Health. Sponsor: Williams, Nikema [Rep.-D-GA-5]; Committees: House – Energy and Commerce
H.R.437 – To amend title X of the Public Health Service Act to require grant recipients to comply with all applicable State and local laws requiring notification or reporting of child abuse, child molestation, sexual abuse, rape, incest, intimate partner violence, or human trafficking, and for other purposes. Sponsor: Smucker, Lloyd [Rep.-R-PA-11]; Committees: House – Energy and Commerce
H.R.436 – To prohibit United States contributions to the United Nations Population Fund. Sponsor: Roy, Chip [Rep.-R- TX-21]; Committees: House – Foreign Affairs
H.R.435 – To prohibit the award of Federal funds to an institution of higher education that hosts or is affiliated with a student-based service site that provides abortion drugs or abortions to students of the institution or to employees of the institution or site, and for other purposes. Sponsor: Roy, Chip [Rep.-R-TX-21]; Committees: House – Education and the Workforce
H.R.434 – To establish certain protections for a member of the Armed Forces, or a cadet or midshipman at a military service academy, who refuses to receive a vaccination against COVID-19. Sponsor: Roy, Chip [Rep.-R-TX-21]; Committees: House – Armed Services
H.R.431 – To implement equal protection under the 14th article of amendment to the Constitution for the right to life of each born and preborn human person. Sponsor: Mooney, Alexander X. [Rep.-R-WV-2]; Committees: House – Judiciary
H.R.429 – To amend the Internal Revenue Code of 1986 to deny the trade or business expense deduction for the reimbursement of employee costs of child gender transition procedure or travel to obtain an abortion. Sponsor: Mast, Brian J. [Rep.-R-FL-21]; Committees: House – Ways and Means
H.R.428 – To amend title 18, United States Code, to prohibit the unlawful disposal of fetal remains. Sponsor: Latta, Robert E. [Rep.-R-OH-5]; Committees: House – Judiciary
H.R.427 – To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes. Sponsor: Latta, Robert E. [Rep.-R-OH-5]; Committees: House – Energy and Commerce
H.R.421 – To prohibit chemical abortions performed without the presence of a healthcare provider, and for other purposes. Sponsor: Good, Bob [Rep.-R-VA-5]; Committees: House – Judiciary
H.R.420 – To amend title XVIII of the Social Security Act to provide for enhanced Medicare beneficiary information through access to annual Medicare notifications in multiple languages. Sponsor: Gomez, Jimmy [Rep.-D-CA-34]; Committees: House – Ways and Means; Energy and Commerce
H.R.417 – To provide a set-aside of funds for Indian populations under the health profession opportunity grant program under section 2008 of the Social Security Act, and for other purposes. Sponsor: Gomez, Jimmy [Rep.-D-CA-34]; Committees: House – Ways and Means
H.R.416 – To amend title IV of the Public Health Service Act to prohibit sale or transactions relating to human fetal tissue. Sponsor: Franklin, C. Scott [Rep.-R-FL-18]; Committees: House – Energy and Commerce
H.R.411 – To ensure that Members of Congress and Congressional staff receive health care from the Department of Veterans Affairs instead of under the Federal Health Benefits Program or health care exchanges. Sponsor: Davidson, Warren [Rep.-R-OH-8]; Committees: House – House Administration; Veterans’ Affairs
H.R.410 – To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Davidson, Warren [Rep.-R-OH-8]; Committees: House – Energy and Commerce
H.R.407 – To prohibit the use of Federal funds to implement Executive order relating to reproductive health services. Sponsor: Clyde, Andrew S. [Rep.-R-GA-9]; Committees: House – Energy and Commerce; Judiciary; Ways and Means
H.R.405 – To amend the Public Health Service Act to provide for stockpiles to ensure that all Americans have access to generic drugs at risk of shortage, and for other purposes. Sponsor: Carter, Earl L. “Buddy” [Rep.-R-GA-1]; Committees: House – Energy and Commerce
H.R.403 – To prohibit COVID-19 vaccination mandates, and for other purposes. Sponsor: Biggs, Andy [Rep.-R-AZ-5]; Committees: House – Oversight and Accountability; House Administration; Energy and Commerce
H.R.401 – To prohibit the Director of the National Science Foundation from awarding grants and other forms of assistance to Chinese communist military companies and their affiliates, and for other purposes. Sponsor: Allen, Rick W. [Rep.-R-GA-12]; Committees: House – Science, Space, and Technology
H.R.398 – To amend the Public Health Service Act to prohibit the Secretary of Health and Human Services from conducting or supporting any research involving human fetal tissue that is obtained pursuant to an induced abortion, and for other purposes. Sponsor: Luetkemeyer, Blaine [Rep.-R-MO-3]; Committees: House – Energy and Commerce
S.Res.12 – A resolution designating January 23, 2023, as “Maternal Health Awareness Day”; Sponsor: Booker, Cory A. [Sen.-D-NJ]; Committees: Senate – Judiciary
S.8 – A bill to amend the Internal Revenue Code of 1986 to expand eligibility for the refundable credit for coverage under a qualified health plan, to improve cost-sharing subsidies under the Patient Protection and Affordable Care Act, and for other purposes; Sponsor: Shaheen, Jeanne [Sen.-D-NH]; Committees: Senate – Finance
S.15 – A bill to amend title XIX of the Social Security Act and the Public Health Service Act to improve the reporting of abortion data to the Centers for Disease Control and Prevention, and for other purposes; Sponsor: Ernst, Joni [Sen.-R-IA]; Committees: Senate – Finance
S.18 – A bill to amend title 18, United States Code, to prohibit discrimination by abortion against an unborn child on the basis of Down syndrome; Sponsor: Daines, Steve [Sen.-R-MT]; Committees: Senate – Judiciary
S.24 – A bill to fight homelessness in the United States by authorizing a grant program within the Health Resources and Services Administration for housing programs that offer comprehensive services and intensive case management for homeless individuals and families; Sponsor: Feinstein, Dianne [Sen.-D-CA]; Committees: Senate – Health, Education, Labor, and Pensions
S.33 – A bill to rescue domestic medical product manufacturing activity by providing incentives in economically distressed areas of the United States and its possessions; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Finance
S.36 – A bill to review domestic biopharmaceutical manufacturing capabilities in order to improve public health and medical preparedness and response capabilities and domestic biopharmaceutical manufacturing capabilities; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Health, Education, Labor, and Pensions
S.48 – A bill to amend title V of the Social Security Act to establish a grant program for community-based maternal mentoring programs; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Finance
S.55 – A bill to limit the detailing of directors of medical centers of the Department of Veterans Affairs to different positions within the Department, and for other purposes; Sponsor: Boozman, John [Sen.-R-AR]; Committees: Senate – Veterans’ Affairs
H.Res.55 – Recognizing the roles and the contributions of Americas Certified Registered Nurse Anesthetists (CRNAs) and their critical role in providing quality health care for the public and the Nation’s Armed Forces for more than 150 years, through multiple public health emergencies, and beyond; Sponsor: Schakowsky, Janice D. [Rep.-D-IL-9]; Committees: House – Energy and Commerce
H.R.451 – To amend title 18, United States Code, to criminalize abuse with respect to assisted reproductive technology, and for other purposes; Sponsor: Bice, Stephanie I. [Rep.-R-OK-5]; Committees: House – Judiciary
H.R.456 – To amend the Federal Food, Drug, and Cosmetic Act with respect to limitations on exclusive approval or licensure of orphan drugs, and for other purposes; Sponsor: Carter, Earl L. “Buddy” [Rep.-R-GA-1]; Committees: House – Energy and Commerce
H.R.459 – To ensure the privacy of pregnancy termination or loss information under the HIPAA privacy regulations and the HITECH Act; Sponsor: Eshoo, Anna G. [Rep.-D-CA-16]; Committees: House – Energy and Commerce
H.R.461 – To amend title 18, United States Code, to prohibit discrimination by abortion against an unborn child on the basis of Down syndrome; Sponsor: Estes, Ron [Rep.-R-KS-4]; Committees: House – Judiciary
H.R.467 – To amend the Controlled Substances Act with respect to the scheduling of fentanyl-related substances, and for other purposes; Sponsor: Griffith, H. Morgan [Rep.-R-VA-9]; Committees: House – Energy and Commerce; Judiciary
H.R.468 – To amend title XI of the Social Security Act to extend beyond the COVID-19 emergency period, with certain modifications, the Emergency Declaration Blanket Waiver relating to training and certification of nurse aides to alleviate burdens imposed on staff of skilled nursing facilities and nursing facilities; Sponsor: Guthrie, Brett [Rep.-R-KY-2]; Committees: House – Energy and Commerce; Ways and Means
H.R.472 – To require the Attorney General to propose a program for making treatment for post-traumatic stress disorder and acute stress disorder available to public safety officers, and for other purposes; Sponsor: Joyce, David P. [Rep.-R- OH-14]; Committees: House – Judiciary
H.R.477 – To amend title V of the Social Security Act to establish a grant program for community-based maternal mentoring programs; Sponsor: Miller, Carol D. [Rep.-R-WV-1]; Committees: House – Energy and Commerce
H.R.485 – To amend title XI of the Social Security Act to prohibit the use of quality-adjusted life years and similar measures in coverage and payment determinations under Federal health care programs; Sponsor: McMorris Rodgers, Cathy [Rep.-R-WA-5]; Committees: House – Energy and Commerce; Ways and Means
H.R.492 – To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to establish a patient outreach system relating to mental health care, and for other purposes; Sponsor: Wittman, Robert J. [Rep.-R-VA-1]; Committees: House – Veterans’ Affairs
S.76 – A bill to require the Secretary of Health and Human Services to furnish tailored information to expecting mothers, and for other purposes; Sponsor: Rubio, Marco [Sen.-R-FL]; Committees: Senate – Health, Education, Labor, and Pensions
Recently Introduced Health Legislation Contd.
S.79 – A bill to amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes; Sponsor: Durbin, Richard J. [Sen.-D-IL]; Committees: Senate – Judiciary
S.80 – A bill to establish an Inspector General of the National Institutes of Health; Sponsor: Blackburn, Marsha [Sen.-R- TN]; Committees: Senate – Health, Education, Labor, and Pensions
S.81 – A bill to provide a moratorium on all Federal research grants provided to any institution of higher education or other research institute that is conducting gain-of-function research; Sponsor: Marshall, Roger [Sen.-R-KS]; Latest Action: Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time.
H.R.497 – To eliminate the COVID-19 vaccine mandate on health care providers furnishing items and services under certain Federal health care programs; Sponsor: Duncan, Jeff [Rep.-R-SC-3]; Committees: House – Energy and Commerce; Ways and Means
H.R.498 – To amend title V of the Public Health Service Act to secure the suicide prevention lifeline from cybersecurity incidents, and for other purposes; Sponsor: Obernolte, Jay [Rep.-R-CA-23]; Committees: House – Energy and Commerce
H.R.501 – To amend the Controlled Substances Act to require registrants to decline to fill certain suspicious orders, and for other purposes; Sponsor: Harshbarger, Diana [Rep.-R-TN-1]; Committees: House – Energy and Commerce; Judiciary
H.R.516 – To fight homelessness in the United States by authorizing a grant program within the Health Resources and Services Administration for housing programs that offer comprehensive services and intensive case management for homeless individuals and families; Sponsor: Lieu, Ted [Rep.-D-CA-36]; Committees: House – Financial Services
H.R.517 – To require the Secretary of Health and Human Services to furnish tailored information to expecting mothers, and for other purposes; Sponsor: Mace, Nancy [Rep.-R-SC-1]; Committees: House – Energy and Commerce
H.R.526 – To amend the Occupational Safety and Health Act of 1970 to prohibit the Secretary of Labor from issuing a temporary standard with respect to COVID-19 vaccination or testing, and for other purposes; Sponsor: Tenney, Claudia [Rep.-R-NY-24]; Committees: House – Education and the Workforce
H.R.527 – To void existing non-compete agreements for any employee who is fired for not complying with an employer’s COVID-19 vaccine mandate, and for other purposes; Sponsor: Tenney, Claudia [Rep.-R-NY-24]; Committees: House – Education and the Workforce; Energy and Commerce
S.95 – A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes; Sponsor: Hyde-Smith, Cindy [Sen.-R-MS]; Committees: Senate – Health, Education, Labor, and Pensions
S.100 – A bill to amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes; Sponsor: Casey, Robert P., Jr. [Sen.-D-PA]; Committees: Senate – Finance
S.109 – A bill to amend title XXI of the Social Security Act to prohibit lifetime or annual limits on dental coverage under the Children’s Health Insurance Program, and to require wraparound coverage of dental services for certain children under such program; Sponsor: Cardin, Benjamin L. [Sen.-D-MD]; Committees: Senate – Finance
S.113 – A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes; Sponsor: Grassley, Chuck [Sen.-R-IA]; Committees: Senate – Judiciary
S.114 – A bill to amend the Congressional Budget Act of 1974 respecting the scoring of preventive health savings; Sponsor: Cardin, Benjamin L. [Sen.-D-MD]; Committees: Senate – Budget
S.121 – A bill to amend the Child Nutrition Act of 1966 to require the provision of training and information to certain personnel relating to food allergy identification and response, and for other purposes; Sponsor: Durbin, Richard J. [Sen.-D- IL]; Committees: Senate – Agriculture, Nutrition, and Forestry
S.127 – A bill to prevent unfair and deceptive acts or practices and the dissemination of false information related to pharmacy benefit management services for prescription drugs, and for other purposes; Sponsor: Cantwell, Maria [Sen.-D- WA]; Committees: Senate – Commerce, Science, and Transportation
H.Res.66 – Expressing support for Congress to focus on artificial intelligence; Sponsor: Lieu, Ted [Rep.-D-CA-36]; Latest Action: House – 01/26/2023 Referred to the House Committee on Science, Space, and Technology
H.R.542 – To amend title 38, United States Code, to improve certain programs of the Department of Veterans Affairs for home and community based services for veterans, and for other purposes; Sponsor: Brownley, Julia [Rep.-D-CA-26]; Latest Action: House – 01/26/2023 Referred to the House Committee on Veterans’ Affairs
H.R.543 – To amend title 38, United States Code, to improve the reimbursement of continuing professional education expenses for health care professionals of the Department of Veterans Affairs; Sponsor: Brownley, Julia [Rep.-D-CA-26]; Latest Action: House – 01/26/2023 Referred to the House Committee on Veterans’ Affairs
H.R.544 – To amend title 38, United States Code, to direct the Secretary of Veterans Affairs to provide coverage for infertility treatment and standard fertility preservation services, and for other purposes; Sponsor: Brownley, Julia [Rep.-D- CA-26]; Latest Action: House – 01/26/2023 Referred to the House Committee on Veterans’ Affairs
H.R.547 – To amend title XIX of the Social Security Act to expand access to home and community-based services (HCBS) under Medicaid, and for other purposes; Sponsor: Dingell, Debbie [Rep.-D-MI-6]; Latest Action: House – 01/26/2023 Referred to the House Committee on Energy and Commerce.
H.R.549 – To amend title II of the Social Security Act to eliminate the waiting periods for disability insurance benefits and Medicare coverage for individuals with metastatic breast cancer, and for other purposes; Sponsor: Garbarino, Andrew R. [Rep.-R-NY-2]; Latest Action: House – 01/26/2023 Referred to the House Committee on Ways and Means
H.R.555 – To amend the Defense Production Act of 1950 to ensure the supply of certain medical materials essential to national defense, and for other purposes; Sponsor: Hill, J. French [Rep.-R-AR-2]; Latest Action: House – 01/26/2023 Referred to the House Committee on Financial Services.
H.R.561 – To ensure affordable abortion coverage and care for every person, and for other purposes; Sponsor: Lee, Barbara [Rep.-D-CA-12]; Latest Action: House – 01/26/2023 Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Natural Resources, Armed Services, Veterans’ Affairs, the Judiciary, Oversight and Accountability, and Foreign Affairs.
H.R.568 – To amend the Controlled Substances Act with respect to fentanyl-related substances, and for other purposes; Sponsor: Pappas, Chris [Rep.-D-NH-1]; Latest Action: House – 01/26/2023 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary.
H.R.574 – To prohibit the provision of Federal funds to the National Institutes of Health for the purposes of conducting biological, medical, or behavioral research involving the testing of dogs; Sponsor: Steube, W. Gregory [Rep.-R-FL-17]; Latest Action: House – 01/26/2023 Referred to the House Committee on Energy and Commerce.